Botox vs Pills for Bladder Control: What the Study Found
Many people deal with urge incontinence. Doctors often use drugs to help, but a full cure is not guaranteed. A newer option involves botulinum toxin A. Researchers wanted to see how it stacks up against standard medicine. They gathered 60 people and split them into three equal groups of 20.
One group received 200 units of Botox. Another got 300 units. The third group took antimuscarinic drugs. Everyone was checked for six months. Researchers met with patients in person or called them on the phone. They used a questionnaire called ICIQ-OAB to gather answers.
The group that received 300 units showed a bigger change in nighttime bathroom trips than the other two groups. This difference was statistically significant, with a p-value of 0.018. As for side effects, the first and third groups had none reported. In the second group, four people out of twenty experienced complications. That is 20 percent, with a p-value of 0.03.
Overall, the 200-unit Botox group seemed to do better at reducing how often people needed to urinate compared to the other two approaches. This raises questions. Why did the higher dose show more change at night but more side effects? Is a lower dose worth trying first? Readers might wonder which option balances results and safety best.